1. Home
  2. Detail

@linhgiaydepnu1995: Giày da bóng gót 5p,7p và 9p kiểu dáng đơn giản dễ mang có size từ size35 đến size 42 #giaynu #giaycaogot #giaydabong #giaycongso #xuhuong

shop đồ xinh
shop đồ xinh
Open In TikTok:
Region: VN
Thursday 21 May 2026 13:06:51 GMT
1082
2
0
0

Music

Download

No Watermark .mp4 (7.22MB) No Watermark(HD) .mp4 (7.22MB) Watermark .mp4 (7.4MB) Music .mp3

Comments

There are no more comments for this video.
To see more videos from user @linhgiaydepnu1995, please go to the Tikwm homepage.

Other Videos

Mua về vệ sinh lỗ xỏ khuyên tai nè mng. #ilovetiktok #sansale
Mua về vệ sinh lỗ xỏ khuyên tai nè mng. #ilovetiktok #sansale
#racoonoperator #racoon #liebherr #towercrane
#racoonoperator #racoon #liebherr #towercrane
【質問返答しながら心眼チェイス】前回の動画でコメントしてくれた人本当にありがとうございます❕今回答えられなかった分はまた次で答えていきますし、まだまだコメントで質問募集しています✨#第五人格 #IdentityV #質問コーナー
【質問返答しながら心眼チェイス】前回の動画でコメントしてくれた人本当にありがとうございます❕今回答えられなかった分はまた次で答えていきますし、まだまだコメントで質問募集しています✨#第五人格 #IdentityV #質問コーナー
🎀
🎀"..𝐬𝐨𝐧𝐠.."🎀
fyp pleaae #fypmalaysia #fyp #cap
fyp pleaae #fypmalaysia #fyp #cap
Expand for Serious Side Effects incl. potential for blood to clot, and see profile for the HEMLIBRA full Prescribing Information and Medication Guide. ------ What is HEMLIBRA? HEMLIBRA is a prescription medicine used for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children, ages newborn and older, with hemophilia A with or without factor VIII inhibitors. ------ What is the most important information I should know about HEMLIBRA? HEMLIBRA increases the potential for your blood to clot. People who use activated prothrombin complex concentrate (aPCC; Feiba®) to treat breakthrough bleeds while taking HEMLIBRA may be at risk of serious side effects related to blood clots. -- These serious side effects include: • Thrombotic microangiopathy (TMA), a condition involving blood clots and injury to small blood vessels that may cause harm to your kidneys, brain, and other organs • Blood clots (thrombotic events), which may form in blood vessels in your arm, leg, lung, or head -- Carefully follow your healthcare provider’s instructions regarding when to use an on-demand bypassing agent or factor VIII, and the dose and schedule to use for breakthrough bleed treatment. If aPCC (Feiba®) is needed, talk to your healthcare provider in case you feel you need more than 100 U/kg of aPCC (Feiba®) total. -- Your body may make antibodies against HEMLIBRA, which may stop HEMLIBRA from working properly. Contact your healthcare provider immediately if you notice that HEMLIBRA has stopped working for you (eg, increase in bleeds). -- The most common side effects of HEMLIBRA include: injection site reactions (redness, tenderness, warmth, or itching at the site of injection), headache, and joint pain. These are not all of the possible side effects of HEMLIBRA. You can speak with your healthcare provider for more information. #Hemlibra #emicizumabkxwh #hemophiliaA #RareDisease #DeepTalks #Podcast
Expand for Serious Side Effects incl. potential for blood to clot, and see profile for the HEMLIBRA full Prescribing Information and Medication Guide. ------ What is HEMLIBRA? HEMLIBRA is a prescription medicine used for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children, ages newborn and older, with hemophilia A with or without factor VIII inhibitors. ------ What is the most important information I should know about HEMLIBRA? HEMLIBRA increases the potential for your blood to clot. People who use activated prothrombin complex concentrate (aPCC; Feiba®) to treat breakthrough bleeds while taking HEMLIBRA may be at risk of serious side effects related to blood clots. -- These serious side effects include: • Thrombotic microangiopathy (TMA), a condition involving blood clots and injury to small blood vessels that may cause harm to your kidneys, brain, and other organs • Blood clots (thrombotic events), which may form in blood vessels in your arm, leg, lung, or head -- Carefully follow your healthcare provider’s instructions regarding when to use an on-demand bypassing agent or factor VIII, and the dose and schedule to use for breakthrough bleed treatment. If aPCC (Feiba®) is needed, talk to your healthcare provider in case you feel you need more than 100 U/kg of aPCC (Feiba®) total. -- Your body may make antibodies against HEMLIBRA, which may stop HEMLIBRA from working properly. Contact your healthcare provider immediately if you notice that HEMLIBRA has stopped working for you (eg, increase in bleeds). -- The most common side effects of HEMLIBRA include: injection site reactions (redness, tenderness, warmth, or itching at the site of injection), headache, and joint pain. These are not all of the possible side effects of HEMLIBRA. You can speak with your healthcare provider for more information. #Hemlibra #emicizumabkxwh #hemophiliaA #RareDisease #DeepTalks #Podcast

About

Legal